Track Concord Medical Services Holdings Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Concord Medical Services Holdings Limited CCM Open Concord Medical Services Holdings Limited in new tab

5.17 USD
EPS
-3.14
P/B
-0.07
ROE
-21.88
Beta
-1.22
Loading chart...
Key Metrics
Earnings dateSept. 25, 2026
EPS-3.14
Book Value-71.12
Price to Book-0.07
Debt/Equity195.39
% Insiders17.995%
Growth
Revenue Growth0.57%
Estimates
Forward P/E-34.47
Forward EPS-0.15

DCF Valuation

Tweak assumptions to recompute fair value for Concord Medical Services Holdings Limited (CCM)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Concord Medical Services Holdings Limited Logo Concord Medical Services Holdings Limited Analysis (CCM)

China Health Care Official Website Stock

Is Concord Medical Services Holdings Limited a good investment? Concord Medical Services Holdings Limited (CCM) is currently trading at 5.17 USD.

Earnings Schedule: Concord Medical Services Holdings Limited is expected to release its next earnings report on Sept. 25, 2026. The market consensus estimate for Forward EPS is -0.15.

Investor FAQ

Does Concord Medical Services Holdings Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Concord Medical Services Holdings Limited?

Concord Medical Services Holdings Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Sept. 25, 2026. The company currently has a trailing EPS of -3.14.

Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Exchange Ticker
NYQ (United States) CCM
Historical Dividends
Year Total Dividends
2016 0.99 USD
2014 1.62 USD
2011 0.18 USD

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Jan. 16, 2014 1.140000
July 30, 2024 0.100000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion